ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages

Cited by (141)

Items 101–141 of 141

1. Exploiting oxidized lipids and the lipid‐binding GPCRs against cardiometabolic diseases
   Raphael Campos Guimarães, Tiago Tomazini Gonçalves, Luiz Osório Leiria · 2020 · British Journal of Pharmacology
2. Fluorescent probe-mediated labeling and real-time tracking of lipid droplet dynamics in foam cells formation
   Jiandong Liu, Xingfang Wang, Jingyi Yu, Jinyu Fu, Qingju Zhang, Jiaojiao Pang, Jiaojiao Pang, Yuguo Chen · 2024 · Sensors and Actuators B Chemical
3. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease
   Matthew R. Spite, Gabrielle Fredman · 2023 · Advances in pharmacology
4. Chemerin 15 enhances microglial phagocytosis to attenuate cerebral ischemia-reperfusion injury through the ChemR23/p38 MAPK pathway
   Yuhan Yang, Yan Huang, Jun Li, Kunyi Li, Changhao Mao, Gang Liu, Shuang Li, Lan Wen · 2025 · iScience
5. Inflammation-resolution signalling in cardiac repair, remodelling, and heart failure
   Ganesh V. Halade, M. Bäck, Vasundhara Kain · 2025 · European Heart Journal Open
6. Proresolving receptor tames inflammation in atherosclerosis
   Hebe Agustina Mena, Matthew R. Spite · 2021 · Journal of Clinical Investigation
7. Signaling through Free Fatty Acid Receptor 4 Attenuates Cardiometabolic Disease
   Timothy D. O’Connell, Katherine A. Murphy, Naixin Zhang, Sara J. Puccini, Chastity L. Healy, Brian A. Harsch, Michael J. Zhang, Gregory C. Shearer · 2022 · Physiology
8. RvE1/ChemR23 facilitates hematoma clearance and promotes M2 polarization of macrophages/microglia in intracerebral hemorrhage
   Mei Fang, Fan Xia, Bang Teng, Wanting Xia, Yunfei Yang, Jiayan Wang, Chuanyuan Tao, Xin Hu · 2025 · Experimental Neurology
9. EPA Induces an Anti-Inflammatory Transcriptome in T Cells, Implicating a Triglyceride-Independent Pathway in Cardiovascular Risk Reduction
   Nathalie A. Reilly, Koen F. Dekkers, Jeroen Molenaar, Sinthuja Arumugam, Thomas B. Kuipers, Yavuz Ariyürek, Marten A. Hoeksema, J. Wouter Jukema, Bastiaan T. Heijmans · 2024 · JACC Basic to Translational Science
10. Structural basis of CMKLR1 signaling induced by chemerin9
    Xuan Zhang, Tina Weiß, Mary Hongying Cheng, Siqi Chen, Carla Katharina Ambrosius, Anne Sophie Czerniak, Kunpeng Li, Mingye Feng, İvet Bahar, Annette Gabriele Beck‐Sickinger et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
11. Potential and Future Therapeutic Applications of Eicosapentaenoic/Docosahexaenoic Acid and Probiotics in Chronic Low-Grade Inflammation
    Amedeo Amedei, Ingrid Lamminpää, Cinzia Parolini · 2025 · Biomedicines
12. Exploring receptors for pro-resolving and non-pro-resolving mediators as therapeutic targets for sarcopenia
    Tiantian Wang, Sihan Chen, Dong Zhou, Zhen Hong · 2025 · Metabolism
13. Anti-Atherogenic Actions of the Lab4b Consortium of Probiotics In Vitro
    Victoria L. O’Morain, Jing Chen, Sue F Plummer, Daryn R. Michael, Dipak P. Ramji · 2023 · International Journal of Molecular Sciences
14. Dynamic changes in proresolving lipid mediators and their receptors following acute vascular injury in male rats
    Hideo Kagaya, Alexander S. Kim, Mian Chen, Pei‐Yu Lin, Xuanzhi Yin, Matthew R. Spite, Michael S. Conte · 2024 · Physiological Reports
15. Fish Intake, Circulating Mercury and Mortality in Renal Transplant Recipients
    Camilo G. Sotomayor, Antonio W. Gomes Neto, Rijk O. B. Gans, Martin H. de Borst, Stefan P. Berger, Ramón Rodrigo, Gerjan J Navis, Daan Johannes Touw, Stephan J. L. Bakker · 2018 · Nutrients
16. Resolvin E1-Chemerin receptor 1 axis is dysregulated in critical COVID-19 patients
    Carolina Silva-Pereira, Marta Reina‐Couto, Patrícia Pereira‐Terra, Luísa Teixeira-Santos, Sandra Martins, Dora Pinho, Miguel Luz Soares, Cláudia Camila Dias, António Sarmento, Margarida Tavares et al. · 2025 · International Immunopharmacology
17. Atherosclerotic progression at sites of low shear stress is attenuated by myeloid-PlexinD1 deficiency through suppression of classical macrophage polarization
    Mingrui Ma, Yingqian Zhang, Lei Gao, Ziqian Wang, Ran Xin, Mingyi Wang, Chen Zhang, Zeyu Sun, Liangliang Liu, Hui Hui et al. · 2025 · European Heart Journal
18. Pro-resolving Mediators
    William Antônio Gonçalves, Alesandra Côrte Reis Melão, Mauro Martins Teixeira, Bárbara Maximino Rezende, Vanessa Pinho · 2018 · Springer eBooks
19. Atherosclerosis
    Walter Gottlieb Land · 2020 · Springer eBooks
20. Resolvin E1 for reducing vascular calcification
    Neil A. MacRitchie, Pasquale Maffia · 2019 · Cardiovascular Research
21. Long-chain fatty acids rewire macrophage polarization through metabolic reprogramming: mechanisms and disease implications
    Chenpeng He, Yuhao Liu, Kaikai Lv, Zichuan An, Chenyu Xue, Na Dong · 2026 · International Immunopharmacology
22. Life cycle of macrophages in atherosclerotic inflammation progression and resolution: mediators and interventions (narrative review)
    Yuxiao Feng, Qinlan Wang, Bin He, Xumin Hou · 2024 · Emergency and Critical Care Medicine
23. The sprouting angiogenesis and vascular dysfunction triggered by bisphenol S and tetrabromobisphenol S through disrupting vascular endothelial-cadherin in zebrafish
    Hongyuan Peng, Zehui Du, Jiali Li, Weiwei Wang, Ze Li, Shaoguo Ru · 2025 · Environmental Research
24. The unbalance of adiponectin oligomers, RvE1 and chemerin levels are associate with increase of adiposopathy status and insulin resistance in obesity
    Perla-Monserrat Madrigal-Ruíz, F. Corona-Meraz, Petri MH, Mónica Vázquez-Del Mercado, Milton-Omar Guzmán-Ornelas, Griselda Guadalupe Macías-López, G-I Diaz-Rubio, Rosa Elena Navarro-Hernández · 2020 · Journal of Translational Science
25. Pro-resolving Mediators
    Hildur H. Arnardottir, Magnus Bäck · 2021 · Springer eBooks
26. Free fatty acid receptor 4 (FFAR4) regulates cardiac oxylipin balance to promote inflammation resolution in a model of heart failure preserved ejection fraction secondary to metabolic syndrome
    Naixin Zhang, Katherine A. Murphy, Brian A. Harsch, Michael J. Zhang, Dylan J. Gyberg, Brandon M. Wagner, Jenna B. Mendelson, Michael T. Patterson, Devin A. Orchard, Chastity L. Healy et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
27. Pro-resolving Mediators
    Hildur H. Arnardottir, Magnus Bäck · 2021 · Springer eBooks
28. ChemR23 activation attenuates cognitive impairment in chronic cerebral hypoperfusion via inhibiting NLRP3 inflammasome-induced neuronal pyroptosis
    Yaxuan Zhang, Jiawei Zhang, Yao Zhao, Yueqi Zhang, Lan Liu, Xu Xiaofeng, Xiuzhe Wang, Jianliang Fu · 2022 · Research Square
29. AB1532 ULTRASOUND ASSESSMENT OF A1 AND A2 PULLEY ENTHESIS WITH ANATOMICAL AND HISTOLOGICAL CORRELATION
    Luis Coronel, Maribel I. Miguel, Juan Blasi, Sara Marsal, Maria Antonietta D’Agostino, Ingrid Möller · 2023 · Annals of the Rheumatic Diseases
30. Eicosapentaenoic acid induces an anti-inflammatory transcriptomic landscape in T cells implicating a pathway independent of triglyceride lowering in cardiovascular risk reduction
    Nathalie A. Reilly, Koen F. Dekkers, Jeroen Molenaar, Sinthuja Arumugam, Thomas B. Kuipers, Yavuz Ariyürek, Marten A. Hoeksema, J. Wouter Jukema, Bastiaan T. Heijmans · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
31. La résolution de l’inflammaging et le processus du vieillissement vasculaire
    Magnus Bäck · 2025 · Bulletin de l Académie Nationale de Médecine
32. Resolvin E1, Resolvin D1 and Carvacrol in Rotator Cuff Tears: Pro-Resolving and Antioxidant Mechanisms with Implications for Tendon-to-Bone Healing
    Recep Taşkın, Fatih Uğur, Mehmet Ali Sabir, Murat Topal · 2026 · Applied Sciences
33. Chemical insights into marine lipid oxidation and its dual role in atherosclerosis: implications for food processing and functional food development
    Jing Xue, Z. Hu, Hongjie Chen, Jiaqi Wang, Xiaoping Yang, Funing Huang, Shiqi Wang, Hailong Xiao, Jianjun Jiang, Xinyuan Wang et al. · 2026 · Food Chemistry
34. Fatty acid metabolites concentration in the early phase of myocardial infarction and its relation to left ventricular ejection fraction
    Szymon Olędzki, Arnold Kukowka, Aldona Siennicka, Radosław Kiedrowicz, Małgorzata Zielska, Ewa Stachowska, Dominika Maciejewska · 2026 · Prostaglandins & Other Lipid Mediators
35. Tissue-Specific Chemerin in Atherosclerosis
    Muyun Chen, Yuxin Li, Feng Linling, Longhua Liu · 2026 · Biomolecules
36. Dysregulated Resolution of Inflammation in Atherosclerosis: Mechanistic Insights and Therapeutic Opportunities
    Manikandan Subramanian · 2026 · Current topics in microbiology and immunology
37. A modified chitosan-based inflammation-regulating nanoplatform as a noninvasive carrier for macromolecular ophthalmic drug delivery toward synergistic AMD treatment
    Haibin Zhao, Qiang Zhang, Jingjing Shen, Yuan Fang, Xinying Lv, Yu Miao, Baoye Ma, Siyu Shuai, Zhuyu Hou, Linfu Chen et al. · 2026 · Materials Horizons
38. Specialized pro-resolving mediators and cancer: news and promises from the other side of the moon
    V. Gatti, G. Colella, F. Violante, V. M. Fazio, M. Cioce · 2026 · Frontiers in Pharmacology
39. Resolution Medicine: Steps to Uncovering the Specialized Pro-resolving Mediator Superfamily and Their Potent Functions in Resolving Inflammation
    Charles Nicholas Serhan · 2026 · Current topics in microbiology and immunology
40. Role of 12/15-lipoxygenase and its metabolites in cardiovascular diseases
    Jiaqi Yu, Weicheng Ni, Yuanzhen Lin, Yanlin Gao, Jianghua Zhou, Yuyu Li · 2026 · Journal of Lipid Research
41. Synthetic analogs of specialized proresolving mediators: From chemical design to therapeutic prospects in atherosclerosis
    Stanislav Kotlyarov · 2026 · Studies in natural products chemistry